We are live on ! Find out more
AV

Arboretum Ventures Portfolio holdings

AUM $1.72M
1-Year Est. Return 82.7%
This Fund
S&P 500
This Quarter Est. Return
-4.55%
1 Year Est. Return
-82.7%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$29.7M
AUM Growth
-$4.19M
Cap. Flow
-$2.77M
Cap. Flow %
-9.31%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PEAR
Pear Therapeutics, Inc. Class A Common Stock
PEAR
+$2.77M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQRX
1
DELISTED
EQRx, Inc. Common Stock
EQRX
$25.9M 87.18%
13,935,623
– –
INGN icon
2
Inogen
INGN
$146M
$3.81M 12.82%
330,000
– –
PEAR
3
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
– –
-10,859,050
Closed -$2.77M

Similar funds

TMC
TVL Management Corporation Menlo Park, California $1.84M AUM 0.1% 1-Year Est. Return
TAM
Trikon Asset Management Hong Kong $1.84M AUM 172.11% 1-Year Est. Return
MVPI
Maven Ventures Partners II Palo Alto, California $958K AUM 41.74% 1-Year Est. Return
RIA
RP Investment Advisors Toronto, Ontario, Canada $900K AUM 17.98% 1-Year Est. Return
ALBM
Alcentra Ltd (BNY Mellon) London, United Kingdom $566K AUM 51.56% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
GM
Gilfoyle Management Branford, Connecticut $49.2K AUM
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return

Arboretum Ventures's Q2 2023 Portfolio in Review

As of Q2 2023, Arboretum Ventures held 3 positions worth $29.7M, down 12% from $33.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Arboretum Ventures withdrew a net $2.77M in Q2 2023, closing 1 position. Its most notable exit was Pear Therapeutics, Inc. Class A Common Stock, an estimated $2.77M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Arboretum Ventures fully exited Pear Therapeutics, Inc. Class A Common Stock in Q2 2023, selling an estimated $2.77M.
  • Arboretum Ventures's ten largest holdings make up 100% of its $29.7M portfolio in Q2 2023.
  • Arboretum Ventures opened 0 new positions and closed 1 in Q2 2023.
  • Arboretum Ventures's portfolio value fell 12% quarter-over-quarter to $29.7M.

Based on Arboretum Ventures's 13F filing for Q2 2023, filed 21 Jul 2023.